Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) Shares Outstanding (Weighted Average) (2020 - 2025)

Roivant Sciences' Shares Outstanding (Weighted Average) history spans 6 years, with the latest figure at $696.9 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) fell 3.58% year-over-year to $696.9 million; the TTM value through Dec 2025 reached $696.9 million, down 3.58%, while the annual FY2025 figure was $20.5 million, 97.38% down from the prior year.
  • Shares Outstanding (Weighted Average) reached $696.9 million in Q4 2025 per ROIV's latest filing, up from $680.6 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $783.2 million in Q1 2024 to a low of $20.5 million in Q2 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $533.1 million, with a median of $683.6 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Weighted Average): soared 3493.58% in 2024, then plummeted 97.38% in 2025.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $686.6 million in 2021, then grew by 2.4% to $703.1 million in 2022, then increased by 10.48% to $776.8 million in 2023, then fell by 6.96% to $722.7 million in 2024, then dropped by 3.58% to $696.9 million in 2025.
  • Per Business Quant, the three most recent readings for ROIV's Shares Outstanding (Weighted Average) are $696.9 million (Q4 2025), $680.6 million (Q3 2025), and $680.3 million (Q2 2025).